gene in sufferers relapsing immediately after remedy With all the BCL2 antagonist venetoclax. 66 Resistance to those agents continues to be associated with these mutations in all-around 70% of conditions, Despite the fact that they tend to be subclonal as well as their specific position producing resistance should be demonstrated.??? "?????????????